Summit Therapeutics (SMMT) Asset Utilization Ratio (2020 - 2023)
Summit Therapeutics' (SMMT) quarterly Asset Utilization Ratio came in at 0.0 in Q2 2023, down 95.36% YoY from 0.02 in Q2 2022, and down 9.73% on a QoQ basis from 0.0 in Q1 2023.
Summit Therapeutics (SMMT) Asset Utilization Ratio (2020 - 2023) Analysis & Trends
Summit Therapeutics (SMMT) has 4 years of Asset Utilization Ratio data on file, last reported at 0.0 in Q2 2023.
- Quarterly Asset Utilization Ratio fell 95.36% year-over-year to 0.0 in Q2 2023, while the trailing twelve-month figure through Jun 2023 was 0.0 (down 95.36% YoY) and the FY2022 annual result came in at 0.0, down 89.18% from the prior year.
- Asset Utilization Ratio retreated to 0.0 in Q2 2023, from 0.0 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.02 in Q2 2022 to a low of 0.0 in Q2 2023.
- A 4-year average of 0.01 and a median of 0.01 in 2022 frame the typical range for Asset Utilization Ratio.
- Annual changes were most pronounced in 2022 — Asset Utilization Ratio soared 348.67% — and 2023, when it plunged 95.36%.
- Tracing SMMT's Asset Utilization Ratio over 4 years: stood at 0.01 in 2020, then soared by 38.49% to 0.01 in 2021, then tumbled by 88.49% to 0.0 in 2022, then tumbled by 48.05% to 0.0 in 2023.
- The last three Asset Utilization Ratio figures came in at 0.0 (Q2 2023), 0.0 (Q1 2023), and 0.0 (Q4 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.69 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 186.67 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.13 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.90 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.54 |
| 10 | Summit Therapeutics | 10.59 Bn | 9.90 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 0.00 |
| Mar 31, 2023 | 0.00 |
| Dec 31, 2022 | 0.00 |
| Sep 30, 2022 | 0.01 |
| Jun 30, 2022 | 0.02 |
| Mar 31, 2022 | 0.02 |
| Dec 31, 2021 | 0.01 |
| Sep 30, 2021 | 0.01 |
| Jun 30, 2021 | 0.00 |
| Mar 31, 2021 | 0.01 |
| Dec 31, 2020 | 0.01 |